Steven Cohen’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$76.7K Sell
68,473
-231,380
-77% -$284K ﹤0.01% 3703
2026
Q2
$369K Buy
+299,853
New +$299K ﹤0.01% 3305
2026
Q1
– Sell
-106,151
Closed -$165K – 4232
2025
Q4
$165K Sell
106,151
-271,888
-72% -$434K ﹤0.01% 3676
2025
Q3
$597K Buy
+378,039
New +$657K ﹤0.01% 1866
2023
Q4
– Sell
-33,200
Closed -$104K – 2581
2023
Q3
$104K Sell
33,200
-67,800
-67% -$273K ﹤0.01% 1959
2023
Q2
$464K Buy
101,000
+66,800
+195% +$307K ﹤0.01% 1278
2023
Q1
$169K Sell
34,200
-386,857
-92% -$1.9M ﹤0.01% 1531
2022
Q4
$2.3M Buy
421,057
+386,157
+1,106% +$2.37M 0.01% 916
2022
Q3
$227K Buy
+34,900
New +$195K ﹤0.01% 1257

Other funds holding MXCT

Steven Cohen's MXCT Position: Q3 2026 in Review

Steven Cohen reduced its MaxCyte (MXCT) stake by 77% in Q3 2026, selling an estimated $284K and leaving 68,473 shares worth $76.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3703.

Steven Cohen first reported a position in MXCT in Q3 2022 and has held it in 9 quarters since. The position peaked at $2.3M in Q4 2022. 120 funds tracked by Wall St. Rank hold MXCT as of Q3 2026.

  • Steven Cohen held 68,473 shares of MaxCyte worth $76.7K as of Q3 2026.
  • Steven Cohen sold 231,380 MaxCyte shares in Q3 2026, an estimated $284K.
  • MaxCyte made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #3703 holding.
  • Steven Cohen first reported a position in MaxCyte in Q3 2022 and has held it in 9 quarters since.
  • Steven Cohen's MaxCyte position peaked at $2.3M in Q4 2022.
  • 120 funds tracked by Wall St. Rank held MaxCyte as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.